Endoproteinase-protein inhibitor interactions

APMIS

Volumn 107, Issue 1, 1999, Pages 3-10

  Bode, Wolfram ^a   Fernandez Catalan, Carlos ^a   Nagase, Hideaki ^b   Maskos, Klaus ^a  

^a MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Crystal structures; Matrix metalloproteinases (MMPs); Protein inhibitors; Proteinase inhibitor complexes; Proteinases; Tissue inhibitors of metalloproteinases (TIMPs)

Indexed keywords

MATRIX METALLOPROTEINASE; PROTEINASE; PROTEINASE INHIBITOR; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

CRYSTAL STRUCTURE; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; HUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; REVIEW;

EID: 0033040566     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1699-0463.1999.tb01520.x     Document Type: Review

References (40)

1. 1. Neurath H. Evolution of proteolytic enzymes. Science 1984;224:350-7.
2. 2. Gomez DE, Alonso DF, Yoshiji H, Thorgeirsson UP. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol 1997;74:111-22.
3. 3. Clawson GA. Protease inhibitors and carcinogenesis: a review. Cancer Invest 1996; 14 (6): 597-608.
4. 4. Laskowski M Jr, Kato I. Protein inhibitors of proteinases. Ann Rev Biochem 1980;49:593-626.
5. 5. Bode W, Huber R. Natural protein proteinase inhibitors and their interaction with proteinases. Eur J Biochem 1992;204:433-51.
6. 6. Bode W, Huber R. Proteinase-protein inhibitor interactions. Fibrinolysis 1994; 8 (Suppl 1): 161-71.
7. 7. Whisstock J, Skinner R, Lesk AM. An atlas of serpin conformations. TIBS 1998;23:63-7.
8. 8. Carrell RW, Stein PE. The biostructural pathology of the serpins: Critical functioning of sheet opening mechanism. Biol Chem Hoppe-Seyler 1996;377:1-17.
9. 9. Engh RA, Huber R., Bode W, Schulze AJ. Divining the serpin inhibition mechanism: a suicide substrate 'springe'? TIBTECH 1995;13:503-10.
10. 10. Egelund R, Rodenburg KW, Andreasen PA, Rasmussen MS, Guldberg RE, Petersen TE. An ester bond linking a fragment of a serine proteinase to its serpin inhibitor. Biochemistry 1998;37:6375-9.
11. 11. Rees DC, Lipscomb WN. J Mol Biol 1982;160:475-98.
12. 12. Rydel TJ, Ravichandran KG, Tulinsky A, Bode W, Huber R, Roitsch C, Fenton JW. II. The structure of a complex of recombinant hirudin and human a-thrombin. Science 1990;249:277-80.
13. 13. Grütter MG, Priestle JP, Rahuel J, Grossenbacher H, Bode W, Hofsteenge J, Stone SR. Crystal structure of the thrombin-hirudin complex: A novel mode of serine protease inhibitor. EMBO J 1990;9:2361-5.
14. 14. Van de Locht A, Lamba D, Bauer M, Huber R, Friedrich T, Kröger B, Höffken W, Bode W. Two heads are better than one: crystal structure of the insect derived double domain Kazal inhibitor rhodniin in complex with thrombin. EMBO J 1995;14:5149-57.
15. 15. Van de Locht A, Stubbs MT, Bode W, Friedrich T, Bollschweiler C, Höffken W, Huber R. The ornithodorin-thrombin crystal structure, a key to the TAP enigma? The EMBO J 1996;15:6011-7.
16. 16. Fuentes-Prior P, Noeske-Jungblut C, Donner P, Schleuning W-D, Huber R, Bode W. Structure of the thrombin complex with triabin, a lipocalin-like exosite-binding inhibitor derived from a triatomine bug. Proc Natl Acad Sci USA 1997;94:11845-50.
17. 17. Bode W, Engh R, Musil D, Thiele U, Huber R, Karshikov A, Brzin J, Turk Y. The 2.0 Å X-ray crystal structure of chicken egg white cystatin and its possible mode of interaction with cysteine proteinases. The EMBO J 1988;7:2593-9.
18. 18. Stubbs MT, Laber B, Bode W, Huber R, Jerala R, Lenarcic B, Turk V. The refined 2.4 Å X-ray crystal structure of recombinant human stefin B in complex with the cysteine proteinase papain: a novel type of proteinase inhibitor interaction. The EMBO J 1990;9:1939-47.
19. 19. Gomis-Rüth FX, Maskos K, Betz M, Bergner A, Huber R, Suzuki K, Yoshida N, Nagase H, Brew K, Bourenkov GP, Bartunik H, Bode W. Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1. Nature 1997;389:77-81.
20. 20. Bode W, Mayr I, Baumann U, Huber R, Stone SR, Hofsteenge J. The refined 1.9 Å crystal structure of human α-thrombin: Interaction with D-Phe-Pro-Arg chloromethylketone and significance of the Tyr-Pro-Pro-Trp insertion segment. EMBO J 1989;8:3467-75.
21. 21. Bode W, Turk D, Karshikov A. The refined 1.9 Å X-ray crystal structure of D-PheProArg chloromethylketone inhibited human α-thrombin. Structure analysis, overall structure, electrostatic properties, detailed active site geometry, structure-function relationships. Protein Sci 1992;1:426-71.
22. 22. Stubbs MT, Bode W. The clot thickens: clues provided by thrombin structure. TIBS 1995;20:23-8.
23. 23. Vijayalakshmi J, Padmanabhan KP, Mann KG, Tulinsky A. The isomorphous structures of prethrombin2, hirugen-, and PPACK-thrombin: Changes accompanying activation and exosite binding to thrombin. Prot Sci 1994;3:2254-71.
24. 24. Bode W. The transition of bovine trypsinogen in a trypsin-like state upon strong ligand binding. II. The binding of the pancreatic trypsin inhibitor and of isoleucinevaline and of sequentially related peptides to trypsinogen and to p-guanidnobenzoate-trypsinogen. J Mol Biol 1979;127:357-74.
25. 25. Turk Y, Bode W. The cystatins: protein inhibitors of cysteine proteinases. FEBS Lett 1991;285:213-9.
26. 26. Woessner JF, Jr. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991;5:2145-55.
27. 27. Matrisian LM. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 1990;6:121-5.
28. 28. Nagase H. Matrix Metalloproteinases. In: Hooper NM, Ed. Taylor, Francis, editors. Zinc Metalloproteases in Health and Disease, London; 1996. p. 153-204.
29. 29. Coussens LM, Werb Z. Matrix metalloproteinases and the development of cancer. Chem Biol 1996;3:895-904.
30. 30. Murphy G, Willenbrock F. Tissue inhibitors of matrix metalloendopeptidases. Meth Enzym 1995;248:496-510.
31. 31. Willenbrock F, Murphy G. Structure-function relationships in the tissue inhibitors of metalloproteinases. Am J Respir Crit Care Med 1994;150:5165-70.
32. 32. Huang W, Suzuki K, Nagase H, Arumugam S, Van Doren SR, Brew K. Folding and characterization of the amino-terminal domain of human tissue inhibitor of metalloproteinase-1 (TIMP-1) expressed at high yield in E. coli. FEBS Lett 1996;384:155-61.
33. 33. Williamson RA, Martorell G, Carr MD, Murphy G, Docherty AJ, Freedman RB, Feeney J. Solution structure of the active domain of tissue inhibitor of metalloproteinases-2. A new member of the OB fold protein family. Biochemistry 1994;33:11745-59.
34. 34. Bode W. A helping hand for collagenases: the haemopexin-like domain. Structure 1995;3:527-30.
35. 35. Bode W, Gomis-Rüth F-X, Stöcker W. Astacins, serralysins, snake venom and matrix metalloproteinases exhibit identical zinc-binding environments (HEXXHXXGXXH and Met-turn) and topologies and should be grouped into a common family, the 'metzincins'. FEBS Lett 1993;331:134-40.
36. 36. Becker JW, Marcy AI, Rokosz LL, Axel MG, Burbaum JJ, Fitzgerald PMD, Cameron PM, Esser CK, Hagmann WK, Hermes JD, Springer JP. Stromelysin-1: Three-dimensional structure of the inhibited catalytic domain and of the C-truncated proenzyme. Prot Sci 1995;4:1966-76.
37. 37. Grams F, Crimmin M, Hinnes L, Huxley P, Pieper M, Tschesche H, Bode W. Structure determination and analysis of human neutrophil collagenase complexed with a hydroxamate inhibitor. Biochemistry 1995;34:14012-20.
38. 38. Grams F, Reinemer P, Powers JC, Kleine T, Pieper M, Tschesche H, Huber R, Bode W. X-ray structures of human neutrophil collagenase complexed with peptide hydroxamate and peptide thiol inhibitors. Implications for substrate binding and rational drug design. Eur J Biochem 1995;228:830-41.
39. 39. Matthews BW. Structural basis of the action of thermolysin and related zinc peptidases. Acc Chem Res 1988;21:333-40.
40. 40. Li J-Y, Brick P, O'Hare MC, Skarzynski T, Lloyd LF, Curry VA, Clark IM, Bigg HF, Hazlemen BL, Cawston TE, Blow, DM. Structure of full-length porcine synovial collagenase reveals a C-terminal domain containing a calcium-linked, four-bladed beta-propeller. Structure 1995;3:541-9.